The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Screenings decrease incidence of colorectal CA Nearly 550,000 cases of colorectal cancer have been prevented in United States since 1986. HealthDay News – As cancer screening rates have increased, ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

Eating a diet highest in ultra-processed foods is tied to an increased risk of early-onset colorectal cancer when compared ...

GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy and Mounjaro — were linked to improved survival among colon cancer patients in a new observational study from UC San Diego.

AACR: New noninvasive colorectal CA screen promising Multitarget stool DNA-based test has a 98% sensitivity for detecting colorectal cancer. HealthDay News — A new noninvasive test for colorectal ...

HealthDay News — Oophorectomy may lead to increased risk of developing colorectal cancer, according to research reported in the June issue of the British Journal of Surgery. The latest findings are ...

New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer. Ozempic, the cancer ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

Women who ate the most ultra-processed foods had a higher risk of developing polyps that can lead to cancer compared with ...

DAVIS - Colorectal cancer cases are on the rise among a vast majority of younger people across the nation, and it's not exactly clear why. When Shauna Nguyen had side discomfort, her provider blew it ...

Colorectal cancer incidence and mortality rates in California have decreased markedly for men and women in all major racial-ethnic groups since 1990, except for Hispanic men -- a disparity that can be ...